How many drugs treat Malignant neoplasm of liver?

Drug Landscape tracks 1 marketed treatments for Malignant neoplasm of liver (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/malignant-neoplasm-of-liver.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Malignant neoplasm of liver — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Malignant neoplasm of liver (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Malignant neoplasm of liver, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
FLOX	FLOX	Hospira		Thymidylate synthase, Thymidylate synthase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Malignant neoplasm of liver
Hospira · 1 drug in Malignant neoplasm of liver

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Malignant neoplasm of liver:

Cite this brief

Drug Landscape (2026). Malignant neoplasm of liver — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/malignant-neoplasm-of-liver. Accessed 2026-06-10.

Malignant neoplasm of liver full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing